February 23, 2022 Vicore takes major step towards a clinical platform company targeting AT2R – new molecule ready for phase 1
February 22, 2022 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2021 Results Presentation and Webcast